Home/Filings/4/0001209191-17-051748
4//SEC Filing

Ward Ana 4

Accession 0001209191-17-051748

CIK 0001636651other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 6:23 PM ET

Size

5.5 KB

Accession

0001209191-17-051748

Insider Transaction Report

Form 4
Period: 2017-09-05
Ward Ana
SVP and General Counsel
Transactions
  • Award

    Stock Option Grant (Right to Buy)

    2017-09-05+95,00095,000 total
    Exercise: $8.38Exp: 2027-09-04Common Stock (95,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on September 1, 2018 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001716354

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:23 PM ET
Size
5.5 KB